The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy

Joseph C. Koster, Francesco Cadario, Cinzia Peruzzi, Carlo Colombo, Colin G. Nichols, Fabrizio Barbetti

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds